Equine adipose-Derived mesenchymal stem cells: Phenotype and growth characteristics, gene expression profile and differentiation potentials

Cell Journal

Volumn 16, Issue 4, 2015, Pages 456-465

  Faezeh Alipour, D V M ^a   Abbas Parham, D V M ^a   Hossein Kazemi Mehrjerdi, D V M ^a   Hesam Dehghani, D V M ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Adipose; Characterization; Differentiation; Equine; Mesenchymal Stem Cells

Indexed keywords

CD34 ANTIGEN; CD44V ANTIGEN; THY 1 ANTIGEN;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CFU COUNTING; DIGESTION; FIBROBLAST; GENE EXPRESSION PROFILING; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; REGENERATIVE ABILITY; VETERINARY MEDICINE;

EID: 84920973200     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: Preliminary study. Equine Vet J. 2008; 40(2): 178-181
2. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res. 2008; 69(7): 928-937
3. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J. 2003; 35(1): 99-102
4. Ribitsch I, Burk J, Delling U, Geißler C, Gittel C, Julke H, et al. Basic science and clinical application of stem cells in veterinary medicine. Adv Biochem Eng Biotechnol. 2010; 123: 219-263
5. English K, French A, Wood KJ. Mesenchymal stromal cells: Facilitators of successful transplantation?. Cell Stem Cell. 2010; 7(4): 431-442
6. Herthel DJ. Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components. AAEP Proceedings. 2001; 47: 319-321
7. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond). 2005; 2: 8
8. Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C, et al. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Vet J. 2013; 195(1): 98-106
9. Dixon-Shanies D, Rudick J, Knittle JL. Observatons on the growth and metabolic functions of cultured cells derived from human adipose tissue. Proc Soc Exp Biol Med. 1975; 149(2): 541-545
10. Gimble J, Guilak F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy. 2003; 5(5): 362-369
11. De Mattos Carvalho A, Alves AL, Golim MA, Moroz A, Hussni CA, de Oliveira PG, et al. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Vet Immunol Immunopathol. 2009; 132(2-4): 303-306
12. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM. Characterization of equine adipose tissue-derived stromal cells: Adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg. 2007; 36(7): 613-622
13. de Mattos Carvalho A, Alves ALG, de Oliveira PGG, Alvarez CLE, Amorim RL, Hussni CA, et al. Use of adipose tissue-derived mesenchymal stem cells for experimental tendinitis therapy in equines. J Equine Vet Sci. 2011; 31(1): 26-34
14. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A. Markers of stemness in equine mesenchymal stem cells: A plea for uniformity. Theriogenology. 2011; 75(8): 1431-1443
15. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-317
16. Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O, Johnson JR, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg. 2008; 37(8): 713-724
17. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J. 2009; 50(2): 155-165
18. Bravo MO, Moraes JM, Dummont CBS, Filgueiras RR, Hashimoto HH, Godoy RF. Isolation, expansion and characterization of equine adipose tissue derived stem cells. Ars Vet. 2012; 28: 66-74
19. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4(5): 267-274
20. Koch T, Heerkens T, Thomsen P, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol. 2007; 7: 26
21. Grzesiak J, Marycz K, Czogala J, Wrzeszcz K, Nicpon J. Comparison of behavior, morphology and morphometry of equine and canine adipose derived mesenchymal stem cells in culture. Int J Morphol. 2011; 29(3): 1012-1017
22. Tepliashin AS, Chupikova NI, Korzhikova SV, Sharifullina SZ, Rostovskaya MS, Savchenkova IP. Comparative analysis of cell populations with a phenotype similar to that of mesenchymal stem cells derived from subcutaneous fat. Tsitologiia. 2005; 47(7): 637-643
23. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006; 24(2): 376-385
24. Schwarz C, Leicht U, Rothe C, Drosse I, Luibl V, Rocken M, et al. Effects of different media on proliferation and differentiation capacity of canine, equine and porcine adipose derived stem cells. Res Vet Sci. 2012; 93(1): 457-462
25. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13(12): 4279-4295
26. Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, et al. Isolation, growth and differentiation of equine mesenchymal stem cells: Effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Vet Res Commun. 2009; 33(8): 811-821
27. Pascucci L, Mercati F, Marini C, Ceccarelli P, DallAglio C, Pedini V, et al. Ultrastructural morphology of equine adipose-derived mesenchymal stem cells. Histol Histopathol. 2010; 25(10): 1277-1285
28. Radcliffe CH, Flaminio MJ, Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Stem Cells Dev. 2010; 19(2): 269-282
29. Ranera B, Lyahyai J, Romero A, Vazquez FJ, Remacha AR, Bernal ML, et al. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue. Vet Immunol Immunopathol. 2011; 144(1-2): 147-154
30. Guest DJ, Allen WR. Expression of cell-surface antigens and embryonic stem cell pluripotency genes in equine blastocysts. Stem Cells Dev. 2007; 16(5): 789-796
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411): 143-147.